Activity value 76china Buyer&Supplier,Last transaction date:
2026-06-27
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for shenzhen techdow pharmaceuticals co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 22 transactions, with a transaction quantity of 95715.38 and a transaction weight of 33315.46.
Product description
REDESCA 40MG-0.4ML, ENOXAPARIN SODIUMSOLUTI ON FOR INJECTION IN PRE-FILLED SYRINGE (PFS ), 10 PFS PER BOX REDESCA 300MG-3ML, ENOXAP ARIN SODIUM SOLUTION FOR INJECTION IN VIAL, 1 VIAL PER BOX HS CODE:3004909099 Expand
Suppliers
shenzhen techdow pharmaceuticals co.ltd.
Buyers
labs delta s a
POLs
——
PODs
aduanas de medellin
Supply area
China
Purchas area
Colombia
Weight
822.16kg
Amount
208603.26
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO I902609001514, FORMATO 2 DE 2; NOS ACOGEMOS A LO ESTABLECIDO EN EL ARTICULO 477 DEL ESTATUTO TRIBUTARIO, LEY 2010 DE 2019 ARTICULO 12; BIENES EXENTOS DE IVA; NACIONALIZACION PARCIAL DE FACTURA SALEN 140780 UNDS (JERINGAS)CON 1706.01 KG PESO BRUTO EN 391 CARTONES, CUM 20084687-06, PRODUCTO: MEDICAMENTO, NOMBRE DEL PRODUCTO: ENOXAPARINA SIDICA JERINGAS PRELLENADAS 60 MG/0.6 ML, PRINCIPIO ACTIVO: ENOXAPARINA SIDICA, CONCENTRACION: 60 MG/0.6 ML,USO: MEDICAMENTO PARA HUMANO, VIA DE ADMINISTRACION: SUBCUTANEA, FORMA FARMACEUTICA: SOLUCION INYEC TABLE, INDICACIONES Y USO TERAPEUTICO: PROFILAXIS DE ENFERMEDAD TROMBOEMB¿LICA VENOSA(ETV), EN PARTICULAR CUANDO PUEDA ESTARASOCIADA CON CIRUGIA ORTOP¿DICA O GENERAL, PROFILAXIS DEL TROMBOEMBOLISMO EN PACIENTES MEDICOS CONFINADOS A CAMA DE BIDO A UNA ENFERMEDAD AGUDA INCLUYENDO INSUFICIENCIA CARDIACA, FALLAS RESPIRATORIAS, INFECCION SEVERA Y ENFERMEDADES REUMATICAS, MARCA COMERCIAL: LABORATORIOS DELTA, NOMBRE FABRICANTE PRODUCTO TERMINADO: SHENZHEN TECHDOW PHARMACEUTICAL
Expand
+View All
Partners
Total 58
RankCompanyTransactionsPerDetail
1sandoz s.a.
indiabuyer,they trade on 2024-12-08
38636.48%
>
shenzhen techdow pharmaceuticals co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as enoxaparin sodium,injection,sol.
According to the 52wmb.com global trade database, as of 2026-06-27, the company has completed 1058 international trades,
with its main trading regions covering united states,colombia,sri lanka etc.
The core products include HS3004902900,HS3001901000,HS30019000 etc,
often transported via yantian,port hong kong, port amsterdam etc,
and its main trading partners are sandoz s.a.,laboratorio franco colombiano lafrancol s a,slim pharmaceuticals pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shenzhen techdow pharmaceuticals co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.